CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis

Published:2016 Issue:14 Volume:8 Page:7562-7571
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Ieranò Caterina¹²³⁴,Portella Luigi¹²³⁴,Lusa Sara⁵⁶⁷,Salzano Giuseppina⁵⁶⁷⁸⁹,D'Alterio Crescenzo¹²³⁴,Napolitano Maria¹²³⁴,Buoncervello Maria¹⁰¹¹¹²¹³,Macchia Daniele¹⁰¹¹¹²¹³,Spada Massimo¹⁰¹¹¹²¹³,Barbieri Antonio¹⁴²³⁴,Luciano Antonio¹⁴²³⁴,Barone Maria Vittoria¹⁵¹⁶¹⁷⁷,Gabriele Lucia¹⁰¹¹¹²¹³,Caraglia Michele¹⁸¹⁹²⁰⁷,Arra Claudio¹⁴²³⁴,De Rosa Giuseppe⁵⁶⁷,Scala Stefania¹²³⁴

Affiliation:

1. Molecular Immunology and Immune regulation

2. Istituto Nazionale per lo Studio e la Cura dei Tumori

3. Fondazione “G. Pascale”-IRCCS

4. Italy

5. Department of Pharmacy

6. University of Naples Federico II

7. Naples, Italy

8. Center for Pharmaceutical Biotechnology and Nanomedicine

9. Northeastern University

10. Department of Hematology

11. Oncology and Molecular Medicine

12. Istituto Superiore di Sanità

13. Rome, Italy

14. Animal Facility

15. Department of Translational Medical Science and European Laboratory for the Investigation of Food Induced Disease (ELFID)

16. University of Naples

17. Federico II

18. Department of Biochemistry

19. Biophysics and General Pathology

20. Second University of Naples

Abstract

PL-Peptide R potentiates the Peptide R efficacy and efficiently delivers doxorubicin in melanoma lung metastasis.

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2016/NR/C5NR06335C

Reference45 articles.

1. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

2. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

3. Overexpression of Both CXC Chemokine Receptor 4 and Vascular Endothelial Growth Factor Proteins Predicts Early Distant Relapse in Stage II-III Colorectal Cancer Patients

4. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4

5. Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment;Biomedicine & Pharmacotherapy;2023-07

2. CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications;International Journal of Biological Sciences;2023

3. Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy;Pharmaceutics;2022-07-25

4. Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review;Pharmaceutics;2022-01-21

5. Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research;Pharmaceutics;2021-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3